Clinical Characteristics Associated with Long-term Survival in Metastatic Gastric Cancer after Systemic Chemotherapy.
Clinical Characteristics Associated with Long-term Survival in Metastatic Gastric Cancer after Systemic Chemotherapy.
复制标题
与全身化疗后转移性胃癌长期生存相关的临床特征。
DOI:
10.7314/apjcp.2015.16.13.5433
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
K. Muro
中科院分区:
文献类型:
--
作者:
S. Kadowaki;A. Komori;D. Takahari;T. Ura;S. Ito;M. Tajika;Y. Niwa;I. Oze;K. Muro
BACKGROUND
Systemic chemotherapy for patients with metastatic gastric cancer (MGC) is generally palliative, although some patients experience long-term survival after treatment. Thus, we identified clinical characteristics that are associated with long-term survival of patients with MGC after palliative chemotherapy.
MATERIALS AND METHODS
We retrospectively reviewed 514 MGC patients who received systemic chemotherapy at our institution from 2001 to 2008. To identify clinical predictors of survival beyond 2 years, multivariate logistic regression analyses were performed, and 5-year survival rates were estimated among MGC patients following chemotherapy.
RESULTS
Among 514 patients, 96 (19%) and 16 (3%) survived beyond 2 and 5 years, respectively, and performance status of 0 or 1 (odds ratio [OR]=3.39; p=0.01), previous gastrectomy (OR=1.86; p=0.01), single metastatic site (OR=1.80; p=0.03), and normal alkaline phosphatase levels (OR=2.81; p<0.01) were identified as independent predictors of long-term survival. Of the 16 5-year survivors, six were alive at the end of the study and showed no evidence of disease despite cessation of chemotherapy.
CONCLUSIONS
The present data demonstrate distinct clinical characteristics that are associated with long-term survival of MGC patients, and indicated that palliative chemotherapy can be curative in highly selected patients.
影响因子:
51.1
作者:
Koizumi, Wasaburo;Narahara, Hiroyuki;Takeuchi, Masahiro
通讯作者:
Takeuchi, Masahiro